Skip to main content
SpringerLink
Log in

Risks and Benefits of Oral Contraceptives

  • Conference paper
Hormonal Carcinogenesis II

  • 60 Accesses

Abstract

We know more today about the safety of oral contraceptives (OC) than about any other medication. Because millions of healthy women use OC for extended lengths of time, the health effects become an important public health concern. After three decades of extensive study, investigators have demonstrated that OC, when given to healthy women, protect against unwanted pregnancy and its complications, improve health, and may even prolong life (1–5).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Vessey MP (1990) The Jephcott Lecture, 1989: An overview of the benefits and risks of combined oral contraceptives. In Mann RD (ed): Oral contraceptives and breast cancer. Carnforth, England, The Parthenon Publishing Group, pp. 121–136.

    Google Scholar 

  2. Pettiti DB (1994) Safety of birth control pills. In Samuels SE, Smith MD (eds): The pill: From prescription to over the counter. Menlo Park, The Henry J. Kaiser Family Fdn, pp. 77–115.

    Google Scholar 

  3. Harlap S, Kost K, Forrest JD (1991) Preventing pregnancy, protecting health. A new look at birth control choices in the United States. New York, The Alan Guttmacher Institute.

    Google Scholar 

  4. Fortney JA, Harper JM, Potts M (1986) Oral contraceptives and life expectancy. Stud Fam Plann 17:117–125.

    Article  PubMed  CAS  Google Scholar 

  5. Grimes DA (1992) The safety of oral contraceptives: Epidemiologic insights from the first 30 years. Am J Obstet Gynecol 166:1950–1954.

    PubMed  CAS  Google Scholar 

  6. Grimes DA (1990) Breast cancer, the pill and the press. In: Oral contraceptives and breast cancer, Mann RD (ed), Carnforth, England, The Parthenon Publishing Group, 309–322.

    Google Scholar 

  7. The Gallup Organization (1994) Women’s attitudes toward oral contraceptives and other forms of birth control. Princeton, New Jersey, The Gallup Organization.

    Google Scholar 

  8. Prentice RL, Thomas DB (1987) On the epidemiology of oral contraceptives and disease. Adv Cancer Res 49:285–401.

    Article  PubMed  CAS  Google Scholar 

  9. Romieu I, Berlin JA, Colditz G (1990) Oral contraceptives and breast cancer: Review and meta-analysis. Cancer 66:2253–2263.

    Article  PubMed  CAS  Google Scholar 

  10. United Kingdom National Case-Control Study Group (1989) Oral contraceptive use and breast cancer risk in young women. Lancet 1:973–982.

    Google Scholar 

  11. Wingo PA, Lee NC, Ory HW, et al. (1991) Age-specific differences in the relationship between oral contraceptive use and breast cancer. Obstet Gynecol 78:161–170.

    PubMed  CAS  Google Scholar 

  12. Beral V, Hannaford P, Kay C (1988) Oral contraceptive use and malignancies of the genital tract: Results from the Royal College of General Practitioners’ Oral Contraception Study. Lancet 2:1331–1335.

    Article  PubMed  CAS  Google Scholar 

  13. Vessey MP, Smith MA, Yeates D (1986) Return of fertility after discontinuation of oral contraceptives: Influence of age and parity. Brit J Fam Plan 11:120–124.

    Google Scholar 

  14. Bracken MB, Hellenbrand KG, Holford TR (1990) Conception delay after oral contraceptive use: The effect of estrogen dose. Fertil Steril 53:21–27.

    PubMed  CAS  Google Scholar 

  15. Croft P, Hannaford PC (1989) Risk factors for acute myocardial infarction in women: Evidence frpm the Royal College of General Practitioners’ Oral Contraception Study. Brit Med J 298:165–168.

    Article  PubMed  CAS  Google Scholar 

  16. Engel HJ, Engel E, Lichtlen PR (1983) Coronary atherosclerosis and myocardial infarction in young women—Role of oral contraceptives. Eur Heart J 4:1–6.

    PubMed  CAS  Google Scholar 

  17. Adams MR, Clarkson TB, Koritnik DR, Nash HA (1987) Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques. Fertil Steril 47:1010–1018.

    PubMed  CAS  Google Scholar 

  18. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development (1987) The reduction in risk of ovarian cancer associated with oral-contraceptive use. New Engl J Med 316:650–655.

    Article  Google Scholar 

  19. Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development (1987) Combination oral contraceptive use and the risk of endometrial cancer. JAMA 257:796–800.

    Article  Google Scholar 

  20. Grimes DA, Godwin AJ, Rubin A et al (1994) Ovulation and follicular development associated with three low dose oral contraceptives: A randomized controlled trial. Obstet Gynecol 83:29–34.

    PubMed  CAS  Google Scholar 

  21. Caillouette JC, Koehler AL (1987) Phasic contraceptive pills and functional ovarian cysts. Am J Obstet Gynecol 156:1538–1542.

    PubMed  CAS  Google Scholar 

  22. Holt VL, Daling JR, McKnight B, et al. (1992) Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives. Obstet Gynecol 79:529–533.

    PubMed  CAS  Google Scholar 

  23. Lanes SF, Birmann B, Walker AM, Singer S (1992) Oral contraceptive type and functional ovarian cysts. Am J Obstet Gynecol 166:956–961.

    PubMed  CAS  Google Scholar 

  24. Recker RR, Davies M, Hinders SM, et al. (1992) Bone gain in young adult women. JAMA 268:2403–2408.

    Article  PubMed  CAS  Google Scholar 

  25. Ross RK, Pike MC, Vessey MP, et al. (1986) Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives. Brit Med J 293:359–362.

    Article  CAS  Google Scholar 

  26. Gray RH (1987) Toxic shock syndrome and oral contraception. Am J Obstet Gynecol 156:1038.

    PubMed  CAS  Google Scholar 

  27. Spector TD, Hochberg MC (1990) The protective effect of the oral contraceptive pill on rheumatoid arthritis: An overview of the analytic epidemiological studies using meta-analysis. J Clin Epidemiol 43:1221–1230.

    Article  PubMed  CAS  Google Scholar 

  28. Henderson BE, Ross RK, Pike MC (1993) Hormonal chemoprevention of cancer in women. Science 259:633–638.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. David A. Grimes
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Etiology and Prevention of Hormonal Cancers, Hormonal Carcinogenesis Laboratory, University of Kansas Cancer Center, Kansas City, Kansas, USA

    J. Jonathan Li Ph.D. (Professor of Pharmacology, Toxicology, and Therapeutics, Director) (Professor of Pharmacology, Toxicology, and Therapeutics, Director)

  2. Hormonal Carcinogenesis Laboratory, University of Kansas Cancer Center, Kansas City, Kansas, USA

    Sara Antonia Li Ph.D. (Associate Professor of Pharmacology, Toxicology, and Therapeutics) (Associate Professor of Pharmacology, Toxicology, and Therapeutics)

  3. Department of Medical Nutrition, Center for Biotechnology, NOVUM, Huddinge University Hospital, Huddinge, Sweden

    Jan-Åke Gustafsson M.D., Ph.D. (Professor and Chairman, Director) (Professor and Chairman, Director)

  4. Department of Molecular and Cell Biology, Cancer Research Center, University of California, Berkeley, California, USA

    Satyabrata Nandi Ph.D. (Professor of Cell and Development Biology) (Professor of Cell and Development Biology)

  5. Division of Cancer Etiology, Chemical and Physical Carcinogenesis Program, National Cancer Institute, Rockville, Maryland, USA

    Lea I. Sekely Ph.D. (Program Director) (Program Director)

  6. University of Kansas Medical Center, Kansas City, Kansas, USA

    J. Jonathan Li Ph.D. (Professor of Pharmacology, Toxicology, and Therapeutics, Director) & Sara Antonia Li Ph.D. (Associate Professor of Pharmacology, Toxicology, and Therapeutics) (Professor of Pharmacology, Toxicology, and Therapeutics, Director) &  (Associate Professor of Pharmacology, Toxicology, and Therapeutics)

  7. National Institutes of Health, Rockville, Maryland, USA

    Lea I. Sekely Ph.D. (Program Director) (Program Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag New York, Inc.

About this paper

Cite this paper

Grimes, D.A. (1996). Risks and Benefits of Oral Contraceptives. In: Li, J.J., Li, S.A., Gustafsson, JÅ., Nandi, S., Sekely, L.I. (eds) Hormonal Carcinogenesis II. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2332-0_36

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2332-0_36

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7506-0

  • Online ISBN: 978-1-4612-2332-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation